This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Omega-3 Fatty Acids: Omega-3 supplements found in fish oil or certain plant sources are known for their potential cardiovascular benefits. Some studies suggest that omega-3 fatty acids might have a modest effect in reducing triglycerides, lowering blood pressure, and possibly reducing the risk of cardiovascular events. However, their specific role in preventing or treating atherosclerosis is not fully understood.
Antioxidants: Antioxidants like vitamins C and E, as well as coenzyme Q10, are believed to have potential benefits in reducing oxidative stress and inflammation associated with atherosclerosis. However, evidence supporting their effectiveness specifically for preventing or treating atherosclerosis is limited.
Garlic: Some studies suggest that garlic supplements might have mild effects on reducing cholesterol levels and blood pressure, which are risk factors for atherosclerosis. However, the evidence is not conclusive, and more research is needed.
Probiotics: The gut microbiota's influence on cardiovascular health has led to research into the potential role of probiotics in reducing cardiovascular risk factors. Some studies suggest that certain probiotic strains might have modest effects on lowering cholesterol levels or reducing inflammation. However, the evidence supporting their use specifically for atherosclerosis prevention or treatment is limited.
Plant Sterols and Stanols: These compounds, found naturally in certain plant-based foods or available in supplement form, might help lower LDL cholesterol levels. They work by blocking the absorption of cholesterol in the intestines. They might be recommended as part of a heart-healthy diet to help manage cholesterol levels.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
[An animal experiment study on the effect of periodontitis on atherosclerosis].
Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology (Hua Xi Kou Qiang Yi Xue Za Zhi ) Vol: 30 Issue: 3 Pages: 308-13 Pub: 2012 Jun ePub: Authors Wang Z,Zhang M,Yu Z,Shui Y,Ding Y,Lei Y |
| 2 | 📚 |
[No detection of Chlamydia pneumoniae in normal and atherosclerotic femoral arteries by polymerase chain reaction (PCR)--an autopsy study].
Zeitschrift fur Kardiologie (Z Kardiol ) Vol: 92 Issue: 3 Pages: 229-35 Pub: 2003 Mar ePub: Authors Wessely S,Mall G |
| 3 | 📚 |
[Role of several periodontopathogenic microorganisms and tlr4 gene Asp299Gly polymorphism in atherosclerosis pathogenesis].
Zhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol ) Vol: Issue: 5 Pages: 83-6 Pub: 2011 Sep-Oct ePub: Authors Skochko OV,Bobrova NA,Izmaylova OV,Kaidashev IP |
| 4 | 📚 |
[The role of Chlamydia pneumoniae infection in the development of atherosclerosis in humans].
Polskie Archiwum Medycyny Wewnetrznej (Pol Arch Med Wewn ) Vol: 108 Issue: 6 Pages: 1239-44 Pub: 2002 Dec ePub: Authors Kotyla PJ,Sliwinska-Kotyla B,Kucharz EJ |
| 5 | 📚 |
A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice.
Cellular immunology (Cell Immunol ) Vol: 294 Issue: 1 Pages: 25-32 Pub: 2015 Mar ePub: 2015 Jan 30 Authors Sorrentino R,Yilmaz A,Schubert K,Crother TR,Pinto A,Shimada K,Arditi M,Chen S |
| 6 | 📚 |
Association of hyperhomocysteinemia and Chlamydia pneumoniae infection with carotid atherosclerosis and coronary artery disease in Japanese patients.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother ) Vol: 14 Issue: 3 Pages: 232-7 Pub: 2008 Jun ePub: 2008 Jun 24 Authors Sawayama Y,Tatsukawa M,Maeda S,Ohnishi H,Furusyo N,Hayashi J |
| 7 | 📚 |
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
The Journal of infectious diseases (J Infect Dis ) Vol: 181 Suppl 3 Issue: Pages: S402-10 Pub: 2000 Jun ePub: Authors Grayston JT |
| 8 | 📚 |
Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?
Clinical and diagnostic laboratory immunology (Clin Diagn Lab Immunol ) Vol: 6 Issue: 6 Pages: 891-4 Pub: 1999 Nov ePub: Authors Fong IW,Chiu B,Viira E,Jang D,Fong MW,Peeling R,Mahony JB |
| 9 | 📚 |
Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2a signaling.
Cell host & microbe (Cell Host Microbe ) Vol: 32 Issue: 6 Pages: 964-979.e7 Pub: 2024 Jun 12 ePub: 2024 May 15 Authors Wang X,Zhou S,Hu X,Ye C,Nie Q,Wang K,Yan S,Lin J,Xu F,Li M,Wu Q,Sun L,Liu B,Zhang Y,Yun C,Wang X,Liu H,Yin WB,Zhao D,Hang J,Zhang S,Jiang C,Pang Y |
| 10 | 📚 |
Chlamydia pneumoniae and atherosclerosis.
Acta chirurgica Belgica (Acta Chir Belg ) Vol: 102 Issue: 5 Pages: 317-22 Pub: 2002 Oct ePub: Authors Hoymans VY,Bosmans JM,Ieven M,Vrints CJ |
| 11 | 📚 |
Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice.
Infection and immunity (Infect Immun ) Vol: 70 Issue: 9 Pages: 5332-4 Pub: 2002 Sep ePub: Authors Blessing E,Campbell LA,Rosenfeld ME,Kuo CC |
| 12 | 📚 |
Chlamydia pneumoniae and Mycoplasma pneumoniae as Two Emerging Risk Factors in Atherosclerosis: Meta-Analysis Study and Systematic Review.
Infectious disorders drug targets (Infect Disord Drug Targets ) Vol: 22 Issue: 1 Pages: e210921196697 Pub: 2022 ePub: Authors Jalili M,Nourmohammadi H,Sayehmiri K |
| 13 | 📚 |
Chlamydia pneumoniae and other risk factors for atherosclerosis.
The Journal of infectious diseases (J Infect Dis ) Vol: 181 Suppl 3 Issue: Pages: S414-6 Pub: 2000 Jun ePub: Authors Leinonen M |
| 14 | 📚 |
Chlamydia pneumoniae infection induces vascular smooth muscle cell migration via Rac1 activation.
Journal of medical microbiology (J Med Microbiol ) Vol: 63 Issue: Pt 2 Pages: 155-161 Pub: 2014 Feb ePub: 2013 Nov 18 Authors Zhang J,Wang H,Zhang L,Zhang T,Wang B,Li X,Wei J,Zhang L |
| 15 | 📚 |
Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration through a Toll-like receptor 2-related signaling pathway.
Infection and immunity (Infect Immun ) Vol: 81 Issue: 12 Pages: 4583-91 Pub: 2013 Dec ePub: 2013 Sep 30 Authors Wang B,Zhang L,Zhang T,Wang H,Zhang J,Wei J,Shen B,Liu X,Xu Z,Zhang L |
| 16 | 📚 |
Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.
Molecular and cellular biochemistry (Mol Cell Biochem ) Vol: 215 Issue: 1-2 Pages: 123-8 Pub: 2000 Dec ePub: Authors Liu L,Hu H,Ji H,Murdin AD,Pierce GN,Zhong G |
| 17 | 📚 |
Chronic infections and atherosclerosis.
Annals of the New York Academy of Sciences (Ann N Y Acad Sci ) Vol: 1108 Issue: Pages: 594-602 Pub: 2007 Jun ePub: Authors Ayada K,Yokota K,Kobayashi K,Shoenfeld Y,Matsuura E,Oguma K |
| 18 | 📚 |
Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections.
Microorganisms (Microorganisms ) Vol: 8 Issue: 1 Pages: Pub: 2020 Jan 17 ePub: 2020 Jan 17 Authors Cheok YY,Lee CYQ,Cheong HC,Looi CY,Wong WF |
| 19 | 📚 |
Comparison of the oral microbiota of patients with atherosclerosis and healthy controls by denaturing gradient gel electrophoresis.
Cellular and molecular biology (Noisy-le-Grand, France) (Cell Mol Biol (Noisy-le-grand) ) Vol: 70 Issue: 8 Pages: 201-206 Pub: 2024 Sep 8 ePub: 2024 Sep 8 Authors Nazari Z,Ramin Abiri,Mohajerani HR |
| 20 | 📚 |
Coxiella burnetii: a new player in atherosclerosis or an innocent bystander?
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect ) Vol: 21 Issue: 4 Pages: e29 Pub: 2015 Apr ePub: 2014 Nov 18 Authors Chatzidimitriou D,Gavriilaki E,Kirmizis D,Tzimagiorgis G |
| 21 | 📚 |
Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis.
Basic research in cardiology (Basic Res Cardiol ) Vol: 115 Issue: 4 Pages: 47 Pub: 2020 Jun 25 ePub: 2020 Jun 25 Authors Vlacil AK,Schuett J,Ruppert V,Soufi M,Oberoi R,Shahin K,Wächter C,Tschernig T,Lei Y,Liu F,Tietge UJF,Schieffer B,Schuett H,Grote K |
| 22 | 📚 |
Distinct gene signatures in aortic tissue from ApoE-/- mice exposed to pathogens or Western diet.
BMC genomics (BMC Genomics ) Vol: 15 Issue: 1 Pages: 1176 Pub: 2014 Dec 24 ePub: 2014 Dec 24 Authors Kramer CD,Weinberg EO,Gower AC,He X,Mekasha S,Slocum C,Beaulieu LM,Wetzler L,Alekseyev Y,Gibson FC 3rd,Freedman JE,Ingalls RR,Genco CA |
| 23 | 📚 |
Early atherosclerotic plaques show evidence of infection by Chlamydia pneumoniae.
Frontiers in bioscience (Elite edition) (Front Biosci (Elite Ed) ) Vol: 4 Issue: 7 Pages: 2423-32 Pub: 2012 Jun 1 ePub: 2012 Jun 1 Authors Luque A,Turu MM,Rovira N,Juan-Babot JO,Slevin M,Krupinski J |
| 24 | 📚 |
Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
The Journal of infectious diseases (J Infect Dis ) Vol: 183 Issue: 2 Pages: 232-238 Pub: 2001 Jan 15 ePub: 2000 Dec 13 Authors Rothstein NM,Quinn TC,Madico G,Gaydos CA,Lowenstein CJ |
| 25 | 📚 |
Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome.
Frontiers in physiology (Front Physiol ) Vol: 12 Issue: Pages: 645212 Pub: 2021 ePub: 2021 May 24 Authors Ji L,Chen S,Gu G,Zhou J,Wang W,Ren J,Wu J,Yang D,Zheng Y |
| 26 | 📚 |
From coughs to complications: the story of Chlamydia pneumoniae.
Journal of medical microbiology (J Med Microbiol ) Vol: 74 Issue: 4 Pages: Pub: 2025 Apr ePub: Authors Tagini F,Puolakkainen M,Greub G,On Behalf Of The Escmid Study Group For Mycoplasma And Chlamydia Infections Esgmac |
| 27 | 📚 |
Gut microbiome as a biomarker of cardiometabolic disorders.
Annals of agricultural and environmental medicine : AAEM (Ann Agric Environ Med ) Vol: 24 Issue: 3 Pages: 416-422 Pub: 2017 Sep 21 ePub: 2017 Sep 8 Authors Gózd-Barszczewska A,Koziol-Montewka M,Barszczewski P,Mlodzinska A,Huminska K |
| 28 | 📚 |
GUT MICROBIOTA COMPOSITION AND ITS METABOLITES CHANGES IN PATIENTS WITH ATHEROSCLEROSIS AND ATRIAL FIBRILLATION.
Wiadomosci lekarskie (Warsaw, Poland : 1960) (Wiad Lek ) Vol: 75 Issue: 12 Pages: 2994-2999 Pub: 2022 ePub: Authors Melnychuk I,Lizogub VG |
| 29 | 📚 |
Gut microbiota diversity and composition in patients with atherosclerosis analyzed using full-length 16S rRNA gene sequencing.
Minerva cardiology and angiology (Minerva Cardiol Angiol ) Vol: Issue: Pages: Pub: 2025 Mar 28 ePub: 2025 Mar 28 Authors Guo SK,Xu Y,Dai ST,Wang YZ,Zhang J,Hou DZ,Li RG,Gong KM |
| 30 | 📚 |
Helicobacter cinaedi bacterium association with atherosclerosis and other diseases.
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue: Pages: 1371717 Pub: 2024 ePub: 2024 Apr 8 Authors Voronina AK,Arapidi GP |
| 31 | 📚 |
Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis.
Clinical science (London, England : 1979) (Clin Sci (Lond) ) Vol: 105 Issue: 3 Pages: 303-13 Pub: 2003 Sep ePub: Authors Jartti L,Raitakari OT,Järvisalo MJ,Hammar N,Kaprio J,Koskenvuo M,Marniemi J,Saikku P,Rönnemaa T |
| 32 | 📚 |
Immune responses to heat shock protein in Porphyromonas gingivalis-infected periodontitis and atherosclerosis patients.
Journal of periodontal research (J Periodontal Res ) Vol: 38 Issue: 4 Pages: 388-93 Pub: 2003 Aug ePub: Authors Chung SW,Kang HS,Park HR,Kim SJ,Kim SJ,Choi JI |
| 33 | 📚 |
Implications of Porphyromonas gingivalis peptidyl arginine deiminase and gingipain R in human health and diseases.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue: Pages: 987683 Pub: 2022 ePub: 2022 Sep 29 Authors Chow YC,Yam HC,Gunasekaran B,Lai WY,Wo WY,Agarwal T,Ong YY,Cheong SL,Tan SA |
| 34 | 📚 |
Infection as a risk factor for infarction and atherosclerosis.
Annals of medicine (Ann Med ) Vol: 23 Issue: 5 Pages: 539-43 Pub: 1991 ePub: Authors Valtonen VV |
| 35 | 📚 |
Insights into the antiatherogenic molecular mechanisms of andrographolide against Porphyromonas gingivalis-induced atherosclerosis in rabbits.
Naunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol ) Vol: 387 Issue: 12 Pages: 1141-52 Pub: 2014 Dec ePub: 2014 Aug 30 Authors Al Batran R,Al-Bayaty F,Al-Obaidi MM,Ashrafi A |
| 36 | 📚 |
Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 34 Issue: 11 Pages: 14166-14181 Pub: 2020 Nov ePub: 2020 Sep 17 Authors Liu S,Zhao W,Liu X,Cheng L |
| 37 | 📚 |
Multiple inflammatory markers in patients with significant coronary artery disease.
International journal of cardiology (Int J Cardiol ) Vol: 118 Issue: 1 Pages: 81-7 Pub: 2007 May 16 ePub: 2006 Aug 28 Authors Videm V,Wiseth R,Gunnes S,Madsen HO,Garred P |
| 38 | 📚 |
Phocaeicola dorei and Phocaeicola vulgatus Protect against Atherosclerosis by Regulating Gut Immunity.
Journal of atherosclerosis and thrombosis (J Atheroscler Thromb ) Vol: Issue: Pages: Pub: 2025 Jun 18 ePub: 2025 Jun 18 Authors Nakashima H,Shinohara R,Emoto T,Saito Y,Yoshida N,Hirata KI,Murakami T,Mori H,Toyoda A,Sugiyama T,Yamada T,Yamashita T |
| 39 | 📚 |
Porphyromonas gingivalis and its lipopolysaccharide differentially regulate the expression of cathepsin B in endothelial cells.
Molecular oral microbiology (Mol Oral Microbiol ) Vol: 27 Issue: 3 Pages: 137-48 Pub: 2012 Jun ePub: 2012 Jan 28 Authors Huck O,Elkaim R,Davideau JL,Tenenbaum H |
| 40 | 📚 |
Porphyromonas gingivalis HSP60 peptides have distinct roles in the development of atherosclerosis.
Molecular immunology (Mol Immunol ) Vol: 63 Issue: 2 Pages: 489-96 Pub: 2015 Feb ePub: Authors Jeong E,Kim K,Kim JH,Cha GS,Kim SJ,Kang HS,Choi J |
| 41 | 📚 |
Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis.
Archives of oral biology (Arch Oral Biol ) Vol: 59 Issue: 11 Pages: 1183-91 Pub: 2014 Nov ePub: 2014 Jul 24 Authors Cai Y,Kobayashi R,Hashizume-Takizawa T,Kurita-Ochiai T |
| 42 | 📚 |
Proteus mirabilis Targets Atherosclerosis Plaques in Human Coronary Arteries via DC-SIGN (CD209).
Frontiers in immunology (Front Immunol ) Vol: 11 Issue: Pages: 579010 Pub: 2020 ePub: 2021 Jan 8 Authors Xue Y,Li Q,Park CG,Klena JD,Anisimov AP,Sun Z,Wei X,Chen T |
| 43 | 📚 |
Role of Chlamydia pneumoniae-infected macrophages in atherosclerosis developments of the carotid artery.
Neuropathology : official journal of the Japanese Society of Neuropathology (Neuropathology ) Vol: 23 Issue: 1 Pages: 1-8 Pub: 2003 Mar ePub: Authors Kuroda S,Kobayashi T,Ishii N,Ikeda J,Shinohe Y,Houkin K,Iwasaki Y,Nagashima K |
| 44 | 📚 |
Role of JNK and NF-?B pathways in Porphyromonas gingivalis LPS-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells.
Molecular medicine reports (Mol Med Rep ) Vol: 8 Issue: 5 Pages: 1594-600 Pub: 2013 Nov ePub: 2013 Sep 17 Authors Liu B,Wang J,Cheng L,Liang J |
| 45 | 📚 |
Tannerella forsythia BspA increases the risk factors for atherosclerosis in ApoE(-/-) mice.
Oral diseases (Oral Dis ) Vol: 20 Issue: 8 Pages: 803-8 Pub: 2014 Nov ePub: 2013 Dec 26 Authors Lee HR,Jun HK,Choi BK |
| 46 | 📚 |
The effects of recurrent Pseudomonas aeruginosa infection on pulmonary parenchyma and vasculature in rats fed on a cholesterol-rich diet.
Experimental lung research (Exp Lung Res ) Vol: 32 Issue: 7 Pages: 275-85 Pub: 2006 Aug ePub: Authors Ozbudak O,Ogus C,Saba R,Turkay C,Sahin N,Ozbilim G,Kiliçarslan B |
| 47 | 📚 |
The potential pathogenic role of gut microbiota in rheumatic diseases: a human-centred narrative review.
Internal and emergency medicine (Intern Emerg Med ) Vol: Issue: Pages: Pub: 2023 Dec 23 ePub: 2023 Dec 23 Authors Bixio R,Bertelle D,Bertoldo E,Morciano A,Rossini M |
| 48 | 📚 |
Transglutaminase 2 is essential for adherence of Porphyromonas gingivalis to host cells.
Proceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A ) Vol: 111 Issue: 14 Pages: 5355-60 Pub: 2014 Apr 8 ePub: 2014 Mar 24 Authors Boisvert H,Lorand L,Duncan MJ |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 49 | 📚 |
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
PloS one (PLoS One ) Vol: 12 Issue: 7 Pages: e0180648 Pub: 2017 ePub: 2017 Jul 5 Authors Schoemaker MH,Kleemann R,Morrison MC,Verheij J,Salic K,van Tol EAF,Kooistra T,Wielinga PY |
| 50 | 📚 |
Aged garlic oligosaccharides modulate host metabolism and gut microbiota to alleviate high-fat and high-cholesterol diet-induced atherosclerosis in ApoE(-/-) mice.
Food chemistry (Food Chem ) Vol: 463 Issue: Pt 3 Pages: 141409 Pub: 2025 Jan 15 ePub: 2024 Sep 23 Authors Wang X,Cui J,Gu Z,Guo L,Liu R,Guo Y,Qin N,Yang Y |
| 51 | 📚 |
Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice.
Circulation (Circulation ) Vol: 133 Issue: 24 Pages: 2434-46 Pub: 2016 Jun 14 ePub: 2016 Apr 25 Authors Li J,Lin S,Vanhoutte PM,Woo CW,Xu A |
| 52 | 📚 |
Bacillus amyloliquefaciens Protect Against Atherosclerosis Through Alleviating Foam Cell Formation and Macrophage Polarization.
Current microbiology (Curr Microbiol ) Vol: 81 Issue: 9 Pages: 263 Pub: 2024 Jul 13 ePub: 2024 Jul 13 Authors Xue Q,Ma Y,Shao H |
| 53 | 📚 |
Bioactive Peptides from Lupin (Lupinus angustifolius) Prevent the Early Stages of Atherosclerosis in Western Diet-Fed ApoE(-/-) Mice.
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 70 Issue: 27 Pages: 8243-8253 Pub: 2022 Jul 13 ePub: 2022 Jun 29 Authors Santos-Sánchez G,Cruz-Chamorro I,Álvarez-Ríos AI,Álvarez-Sánchez N,Rodríguez-Ortiz B,Álvarez-López AI,Fernández-Pachón MS,Pedroche J,Millán F,Millán-Linares MDC,Lardone PJ,Bejarano I,Carrillo-Vico A |
| 54 | 📚 |
Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?
Clinical and diagnostic laboratory immunology (Clin Diagn Lab Immunol ) Vol: 6 Issue: 6 Pages: 891-4 Pub: 1999 Nov ePub: Authors Fong IW,Chiu B,Viira E,Jang D,Fong MW,Peeling R,Mahony JB |
| 55 | 📚 |
Dandelion Polysaccharides Ameliorate High-Fat-Diet-Induced Atherosclerosis in Mice through Antioxidant and Anti-Inflammatory Capabilities.
Nutrients (Nutrients ) Vol: 15 Issue: 19 Pages: Pub: 2023 Sep 24 ePub: 2023 Sep 24 Authors Zhou S,Wang Z,Hao Y,An P,Luo J,Luo Y |
| 56 | 📚 |
Disulfiram reduces atherosclerosis and enhances efferocytosis, autophagy, and atheroprotective gut microbiota in hyperlipidemic mice.
bioRxiv : the preprint server for biology (bioRxiv ) Vol: Issue: Pages: Pub: 2023 Oct 19 ePub: 2023 Oct 19 Authors Traughber CA,Timinski K,Prince A,Bhandari N,Neupane K,Khan MR,Opoku E,Opoku E,Brubaker G,Nageshwar K,Ertugral EG,Naggareddy P,Kothapalli CR,Smith JD,Gulshan K |
| 57 | 📚 |
E. coli Nissle 1917 improves gut microbiota composition and serum metabolites to counteract atherosclerosis via the homocitrulline/Caspase 1/NLRP3/GSDMD axis.
International journal of medical microbiology : IJMM (Int J Med Microbiol ) Vol: 318 Issue: Pages: 151642 Pub: 2025 Mar ePub: 2024 Dec 26 Authors Liu H,Ma X,Yang X,Xiao S,Ouyang S,Hu Z,Zhou Z,Jiang Z |
| 58 | 📚 |
Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
The Journal of infectious diseases (J Infect Dis ) Vol: 183 Issue: 2 Pages: 232-238 Pub: 2001 Jan 15 ePub: 2000 Dec 13 Authors Rothstein NM,Quinn TC,Madico G,Gaydos CA,Lowenstein CJ |
| 59 | 📚 |
Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.
Atherosclerosis (Atherosclerosis ) Vol: 242 Issue: 1 Pages: 141-4 Pub: 2015 Sep ePub: 2015 Jul 8 Authors Tripolt NJ,Leber B,Triebl A,Köfeler H,Stadlbauer V,Sourij H |
| 60 | 📚 |
Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats.
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 98 Issue: 1 Pages: 115-26 Pub: 2014 Jan ePub: Authors Tomaro-Duchesneau C,Saha S,Malhotra M,Jones ML,Labbé A,Rodes L,Kahouli I,Prakash S |
| 61 | 📚 |
Effect of the polyphenol-rich extract from Allium cepa on hyperlipidemic sprague-dawley rats.
Journal of food biochemistry (J Food Biochem ) Vol: 45 Issue: 1 Pages: e13565 Pub: 2021 Jan ePub: 2020 Nov 20 Authors Li W,Yang C,Mei X,Huang R,Zhang S,Tang Y,Dong Q,Zhou C |
| 62 | 📚 |
eIF6 deficiency regulates gut microbiota, decreases systemic inflammation, and alleviates atherosclerosis.
mSystems (mSystems ) Vol: 9 Issue: 10 Pages: e0059524 Pub: 2024 Oct 22 ePub: 2024 Sep 3 Authors Wang Z,Yang S,Tong L,Li X,Mao W,Yuan H,Chen Y,Zhang S,Zhang H,Chen R |
| 63 | 📚 |
Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe.
Cell communication and signaling : CCS (Cell Commun Signal ) Vol: 22 Issue: 1 Pages: 54 Pub: 2024 Jan 19 ePub: 2024 Jan 19 Authors Yang HT,Jiang ZH,Yang Y,Wu TT,Zheng YY,Ma YT,Xie X |
| 64 | 📚 |
Gallic acid ameliorates atherosclerosis and vascular senescence and remodels the microbiome in a sex-dependent manner in ApoE(-/-) mice.
The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 110 Issue: Pages: 109132 Pub: 2022 Dec ePub: 2022 Aug 24 Authors Clark M,Centner AM,Ukhanov V,Nagpal R,Salazar G |
| 65 | 📚 |
Garlic for Cardiovascular Disease: Prevention or Treatment?
Current pharmaceutical design (Curr Pharm Des ) Vol: 23 Issue: 7 Pages: 1028-1041 Pub: 2017 ePub: Authors Alali FQ,El-Elimat T,Khalid L,Hudaib R,Al-Shehabi TS,Eid AH |
| 66 | 📚 |
Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE(-/-) mice.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 134 Issue: Pages: 111100 Pub: 2021 Feb ePub: 2020 Dec 16 Authors Lv Z,Shan X,Tu Q,Wang J,Chen J,Yang Y |
| 67 | 📚 |
High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE-/- mice.
BMC microbiology (BMC Microbiol ) Vol: 16 Issue: 1 Pages: 264 Pub: 2016 Nov 8 ePub: 2016 Nov 8 Authors Chan YK,Brar MS,Kirjavainen PV,Chen Y,Peng J,Li D,Leung FC,El-Nezami H |
| 68 | 📚 |
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study).
Nutrients (Nutrients ) Vol: 13 Issue: 2 Pages: Pub: 2021 Jan 28 ePub: 2021 Jan 28 Authors Cicolari S,Pavanello C,Olmastroni E,Puppo MD,Bertolotti M,Mombelli G,Catapano AL,Calabresi L,Magni P |
| 69 | 📚 |
Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process.
International immunopharmacology (Int Immunopharmacol ) Vol: 17 Issue: 1 Pages: 108-15 Pub: 2013 Sep ePub: 2013 Jun 5 Authors Chen L,Liu W,Li Y,Luo S,Liu Q,Zhong Y,Jian Z,Bao M |
| 70 | 📚 |
Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice.
Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 80 Issue: 24 Pages: 7496-504 Pub: 2014 Dec ePub: 2014 Sep 26 Authors Huang Y,Wang J,Quan G,Wang X,Yang L,Zhong L |
| 71 | 📚 |
Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.
PloS one (PLoS One ) Vol: 7 Issue: 10 Pages: e46837 Pub: 2012 ePub: 2012 Oct 9 Authors Fåk F,Bäckhed F |
| 72 | 📚 |
Lactobacillus rhamnosus GG protects against atherosclerosis by improving ketone body synthesis.
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 106 Issue: 24 Pages: 8233-8243 Pub: 2022 Dec ePub: 2022 Nov 17 Authors Zhai T,Ren W,Wang P,Zheng L |
| 73 | 📚 |
Notoginsenoside R1 Ameliorate High-Fat-Diet and Vitamin D3-Induced Atherosclerosis via Alleviating Inflammatory Response, Inhibiting Endothelial Dysfunction, and Regulating Gut Microbiota.
Drug design, development and therapy (Drug Des Devel Ther ) Vol: 18 Issue: Pages: 1821-1832 Pub: 2024 ePub: 2024 May 27 Authors Ma L,Gao Y,Yang G,Zhao L,Zhao Z,Zhao Y,Zhang Y,Li S,Li S |
| 74 | 📚 |
Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis.
Nutrition (Burbank, Los Angeles County, Calif.) (Nutrition ) Vol: 79-80 Issue: Pages: 110941 Pub: 2020 Nov-Dec ePub: 2020 Jul 11 Authors Liang X,Zhang Z,Lv Y,Tong L,Liu T,Yi H,Zhou X,Yu Z,Tian X,Cui Q,Yang J,Gong P,Zhang L |
| 75 | 📚 |
Resveratrol and curcumin reduce the respiratory burst of Chlamydia-primed THP-1 cells.
Biochemical and biophysical research communications (Biochem Biophys Res Commun ) Vol: 333 Issue: 1 Pages: 21-7 Pub: 2005 Jul 22 ePub: Authors Deby-Dupont G,Mouithys-Mickalad A,Serteyn D,Lamy M,Deby C |
| 76 | 📚 |
Review of Curcumin Physicochemical Targeting Delivery System.
International journal of nanomedicine (Int J Nanomedicine ) Vol: 15 Issue: Pages: 9799-9821 Pub: 2020 ePub: 2020 Dec 7 Authors Li L,Zhang X,Pi C,Yang H,Zheng X,Zhao L,Wei Y |
| 77 | 📚 |
Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3-2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis.
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue: Pages: Pub: 2024 Dec 21 ePub: 2024 Dec 21 Authors Zheng X,Zhang Z,Shan T,Zhao M,Lu H,Zhang L,Liang X |
| 78 | 📚 |
The Lab4P Consortium of Probiotics Attenuates Atherosclerosis in LDL Receptor Deficient Mice Fed a High Fat Diet and Causes Plaque Stabilization by Inhibiting Inflammation and Several Pro-Atherogenic Processes.
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 65 Issue: 17 Pages: e2100214 Pub: 2021 Sep ePub: 2021 Jul 19 Authors O'Morain VL,Chan YH,Williams JO,Alotibi R,Alahmadi A,Rodrigues NP,Plummer SF,Hughes TR,Michael DR,Ramji DP |
| 79 | 📚 |
Thymoquinone, a major constituent in Nigella sativa seeds, is a potential preventative and treatment option for atherosclerosis.
European journal of pharmacology (Eur J Pharmacol ) Vol: 909 Issue: Pages: 174420 Pub: 2021 Oct 15 ePub: 2021 Aug 12 Authors Majdalawieh AF,Yousef SM,Abu-Yousef IA |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 1933 | 1 | Akkermansia muciniphila {Pendulum Probiotic} | |
| 2896 | 1 | Allium cepa {Onion} | Bulb onion,Common onion |
| 7 | 2 | allium sativum {garlic} | garlic,allium sativum,allium |
| 27 | 1 | azithromycin,[CFS] | (3-micina, a sai qi, abacten, abacten forte, acex, acithroc, actazith, agitro, ai mi qi, amixef, anex-az, ao li ping, apo azithromycine, apo-azithromycin, aruzilina, arzomidol, asomin, aspen azithromycin, astidal, astro, athxin, atromizin, austell-azithromycin, az, az-1, aza, azalide, azasite, azath, azatril, azax, azee, azeecor, azeeta, azeltin, azerkym, azi, azi once, azibact, azibay, azibest, azi-big, azibiot, azicare, aziclass, azicom, azicure, azifam, azifast, azifine, azifine-c, azigen, azigram, azigreat, azikare, azilide, azilife, azilip, azilup, azimax, azimed, azimepha, azimit, azimix, azimon, azimore, azimycin, azimycine, azindamon, azinew, azinex, azinif, azinil, azintra, aziom, azipar, aziped, aziphar, azipin, azipro, aziquilab, azirace, aziram, aziresp, aziride, azirom, aziset, azisis, azison, azissel, aziswift, azita, azitam, aziter-c, azitex, azith, azithrin, azithro, azithrobeta, azithrocine, azithromed, azithromycin, azithromycin 1a pharma, azithromycin actavis, azithromycin clonmel, azithromycin genoptim, azithromycin greenstone, azithromycin grindeks, azithromycin jubuilant, azithromycin kern pharma, azithromycin krka, azithromycin lek, azithromycin neo, azithromycin sandoz, azithromycin teva, azithromycin usp, azithromycine apotex, azithromycine eg, azithromycine mylan, azithromycine sandoz, azithromycine teva, azithromycine winthrop, azithromycinum 123ratio, azithrovid, azitic, azitive, azitome, azitrac, azitral, azitredil, azitrim, azitrin, azitro, azitrobac, azitrogal, azitrolabsa, azitrolek, azitrolit, azitrom, azitromac, azitromek, azitromicin farmal, azitromicin genera, azitromicin pharmas, azitromicin sandoz, azitromicina, azitromicina andromaco, azitromicina azitrix, azitromicina calox, azitromicina cormin, azitromicina ecuaquimica, azitromicina farmandina, azitromicina farmoz, azitromicina genfar, azitromicina l.ch., azitromicina la santé, azitromicina labovida, azitromicina mintlab, azitromicina nexo, azitromicina nifa, azitromicina northia, azitromicina pensa, azitromicina pfizer, azitromicina richet, azitromicina rocnarf, azitromicina sanitas, azitromicina sanofi-aventis, azitromicina terapia, azitromin, azitromycin borisov, azitromycine teva, azitrona, azitropharma, azitroteg, azitrox, azitrox z, azitsa, azitus, azivar, aziwok, azix, azizox, azobat, azocin, azoget, azom, azomac, azomax, azomycin, azomyne, azostar, azoxin, azras, azro, azro-am, azrocin, azrolid, aztin, aztrin, azvig, azycin, azycyna, azydrop, azypin, azytact, azyter, azywell, azza, ba qi, bactrazol, bai ke de rui, bezanin, bin qi, binozyt, binqi, bio-az, bo kang, brutacef-az, canbiox, cetaxim, cezee, chen yu, cinalid, cipla-azithromycin, clearsing, clindal az, corzi, cozith, curazith, delzosin, dentazit, doyle, elzithro, emtax-az, eniz, epica, ethrimax, ezith, fabodrox, feng da qi, fixicom-az, floctil, fu qi-hua yuan, fu rui xin, fuqixing, fuxin-hai xin pharm, geozif, geozit, gitro, gramac, hemomicin, hemomycin, inedol, infectomycin, iramicina, itha, i-thro, jin nuo, jin pai qi, jinbo, jun jie, jun wei qing, kai qi, kang li jian, kang qi, katrozax, ke lin da, ke yan li, koptin, kuai yu, laz, laz-ax, legar, lg-thral, li ke si, li li xing, li qi, lin bi, lipuqi, lipuxin, lizhu qile, loromycin, l-thro, lu jia kang, luo bei er, luo qi, luoxin shoukang, maazi, macroazi, macromax, macrozit, mazit, mazitrom, meithromax, ming qi xin, na qi, nadymax, nemezid, nobaxin, nokar, novozitron, nurox, olcefone-az, oranex, orobiotic, pai fen, pai fu, paiqi, pms-azimax, pu he, pu le qi, pu yang, qi gu mei, qi mai xing, qi nuo, qi tai, qi xian, qili, qiyue, razithro, ribozith, ricilina, rizcin, rozith-sr, ru shuang qi, rui qi, rui qi lin, rulide-az, sai jin sha, sai le xin, sai qi, sandoz-azithromycin, sheng nuo ling, shu luo kang, simpli-3, sisocin, sohomac, starfix-az, su shuang, sumamed, sumamed forte, sumamed s, tailite, tanezox, te li xin, throin, tong tai qi li, topt, tremac, trex, tri azit, tromix, trozin, trulimax, tuoqi, udox, ultreon, unizithrin, vectocilina, vizicin, wei li qing, wei lu de, wei zong, weihong, xerexomair, xi le xin, xi mei, xin da kang, xin pu rui, xithrone, ya rui, yan sha, yanic, yanic-kid, yi nuo da, yi song, yi xin, yin pei kang, yong qi, you ni ke, yu qi, z-3, zady, zaiqi, zarom, zathrin, zathrin-ax, zeemide, zenith, zeph-az, zetamax, zetamax retard, zeto, zetron, zevlen, zibramax, zicho, zicin-cx, zifi-az, zigilex, zikti, zikti-kid, zimax, zindel, zirom, zisrocin, zitab, zitax, zithrax, zithrodose, zithrogen, zithrokan, zithromax, zithrome, zithromed, zithroplus, zithrox, zithrox plus, zithrox plus-kid, zithrox-l, zithrox-m, zithrox-s, zithtec, zitmac, zitric, zitrobid, zitrocin, zitrolab, zitromax, zitroneo, zitrotek, ziyoazi, ziyoazi-kid, zmax, zmax retard, zocin, zomax, zotax-250, zycin, amovin, aratro, arzomicin, asizith, athofix, atizor, azacid, azadose, azalid, azelide, azenil, azeptin, aziact, azibactron, azibect, azibiotic, azicin, azicine, azid, azidose, azidraw, azifarm, azimac, azimex, azin, azi-once, aziprome, azirol, azirox, azirute, azirutec, azit, azi-teva, azithral, azithrocin, azithromax, azithromycin - 1 a pharma, azithromycin +pharma, azithromycin aristopharma, azithromycin astro, azithromycin aurochem, azithromycin eberth, azithromycin genericon, azithromycin generics, azithromycin hec, azithromycin hexal, azithromycin jubilant, azithromycin orifarm, azithromycin pfizer, azithromycin vertex, azithromycin vocate, azithromycin winthrop, azithromycin zentiva, azithromycine biogaran, azithromycine cristers, azithromycine krka, azithromycine pfizer, azithromycine phr lab, azithromycine zentiva, azithromycine zydus, azithromycin-hecpharm, azithromycin-q pharma, azithromycin-ratiopharm, azitrax, azitrex, azitrix, azitrocin, azitroerre, azitrolid, azitromax, azitromicin belupo, azitromicina actavis, azitromicina almus, azitromicina alter, azitromicina apotex, azitromicina aristo, azitromicina baldacci, azitromicina basi, azitromicina bexal, azitromicina bluepharma, azitromicina ciclum, azitromicina cinfa, azitromicina combix, azitromicina cuve, azitromicina davur, azitromicina doc generici, azitromicina fg, azitromicina fimol, azitromicina g.e.s, azitromicina genericos juventus, azitromicina generis, azitromicina germed, azitromicina gp, azitromicina ipso pharma, azitromicina kern pharma, azitromicina korhispana, azitromicina krka, azitromicina labesfal, azitromicina mabo, azitromicina mepha, azitromicina mk, azitromicina mylan, azitromicina mylan generics, azitromicina normon, azitromicina pharmagenus, azitromicina pharmakern, azitromicina proge farm, azitromicina qualigen, azitromicina ratio, azitromicina ratiopharm, azitromicina ratiopharm italia, azitromicina sandoz, azitromicina stada, azitromicina tarbis, azitromicina tecnigen, azitromicina teva, azitromicina teva italia, azitromicina tolife, azitromicina ur, azitromicina vir, azitromicina winthrop, azitromicina zentiva, azitromycin protech, azitromycine actavis, azitromycine apotex, azitromycine jubilant, azivirus, aziwill, azmycin, azo, azoheim, azoksin, azomex, azomicin, azores, azorox, azot, azrosin, aztro, aztrogecin, azytan, azyth, bactizith, batif, bazyt, biozit, charyn, cinetrin, clamelle, cronopen, disithrom, doromax, fabramicina, figothrom, flumax, goldamycin, gramokil, ilozin, imexa, infectoazit, maczith, makromicin, maxmor, medimacrol, mezatrin, misultina, naxocina, neblic, neofarmiz, nifostin, novatrex, novozithron, od mac, odaz, odazyth, onzet, ordipha, portex, rarpezit, razimax, rezan, ribotrex, romycin, rozalid, rozith, selimax, sitrox, stromac, sumamed std, sumamox, talcilina, tetris, texis, thoraxx, thromaxin, toraseptol, triamid, tridosil, trimelin, tritab, trivafluc, tromiatlas, trozamil, trozocina, vinzam, visag, yi ou qing, zaret, zedbac, zentavion, zetamac, zimacrol, zimicina, zinfect, zistic, zithrin, zithrobest, zithro-due, zithrolide, zithromax enfants, zithromax uno, zithrotel, zithroxyn, zitinn, zit-od, zitraval, zitrax genepharm, zitrex, zitrim, zitrobiotic, zitrocin forte, zitrocin s, zitroflam, zitrogram, zitromax md, zmax one dose, zmax sr, z-pak, zythrocin, avalon, az opth soln, azi sandoz, azithromycin abz, azithromycin al, azithromycin arcana, azithromycin aristo, azithromycin dura, azithromycin mylan, azithromycin orion azithromycin, azithromycin sanis health, azithromycin spirig hc, azithromycin stada, azithromycin sterimax, azithromycin-1a pharma, azithromycin-ct, azithromycine arrow, azithromycine evolugen, azithromycine monodose sandoz, azithromycine ranbaxy, azithromycin-mepha, azithro-natrapharm, azitro-acino, azitromicina eg, azitromicina ranbaxy, azitromycin mylan, azitromycin sandoz, azitromycine cf, azitromycine mylan, azitromycine ratiopharm, azitromycine sandoz, azromax, dbl azithromycin, pediazith, riva-azithromycin, sandoz azithromycin, zithromac, zithromac 10%, zithromac sr, an mei qin, pms-azithromycin) |
| 4573 | 1 | Bacillus amyloliquefaciens {B.amyloliquefaciens } | Bacillus sp. BTSS3,Bacillus sp. EnB,Bacillus amyloliquefaciens subsp. plantarum |
| 3008 | 1 | Bifidobacterium animalis {B. animalis} | Bifidobacterium longum subsp. animalis biotype a,Bifidobacterium animalis subsp. lactis |
| 46 | 1 | Bifidobacterium animalis subsp. lactis {B. Lactis} | Includes BB-12, DN-173 010 ,Bifidobacterium Regularis,Bifidus Regularis |
| 51 | 1 | Bifidobacterium longum subsp. longum BB536 {BB536} | Morinaga BB536, robiotic BB536 |
| 1824 | 2 | Diferuloylmethane {Curcumin} | Extract from Turmeric (which contains other chemicals) |
| 793 | 1 | disulfiram,(prescription) | (antabus, antabuse, antaethyl, antalcol, anticol, antietanol, busetal, chronol, disulfiram wzf, disulfix, dsf, esperal, etabus, etiltox, nocbin, refusal, sarcoton, tenutex, tetradin, ulfiram) |
| 297 | 1 | Escherichia coli Nissle 1917 {Mutaflor} | In use since 1917 |
| 4546 | 1 | Faecalibacterium prausnitzii {Faecalibacterium prausnitzii} | Next Generation Probiotic |
| 156 | 1 | gallic acid {gallate} | includes methyl gallate, propyl gallate, gallic acid |
| 1766 | 1 | Ginkgo biloba {Ginkgo} | Ginkgo, gingko, maidenhair tree,Japanese silver apricot |
| 234 | 1 | Lacticaseibacillus casei {L. casei} | Streptobacterium casei,Lactobacillus casei |
| 230 | 3 | lactobacillus acidophilus {L. acidophilus} | Bacillus acidophilus |
| 243 | 1 | Lactobacillus plantarum {L. plantarum} | lactobacillus plantarum, Lactobacillus arabinosus |
| 247 | 3 | lactobacillus rhamnosus gg | l rhamnosus gg (probiotics) |
| 236 | 1 | Limosilactobacillus fermentum {L. fermentum} | Lactobacillus fermentum |
| 245 | 1 | Limosilactobacillus reuteri {L. Reuteri} | Lactobacillus fermentum subsp. reuteri |
| 1703 | 1 | Lupinus {Lupin[Warning]} | bluebonnet,Anaphylaxis Risk |
| 1808 | 1 | macrolide () | |
| 1719 | 1 | Nigella sativa {black cumin} | black seed, black caraway, kalonji,fennel flower |
| 360 | 1 | resveratrol-pterostilbene {grapes, blueberries} | grape seed/polyphenols/red wine |
| 2861 | 1 | Taraxacum officinale {Dandelion} | Lion's tooth,Blowball,Cankerwort,Faceclock,Irish daisy,Piss-in-bed (or pee-a-bed, wet-a-bed),Priest's crown,Yellow gowan |
| 424 | 1 | vitamin d | cholecalciferol,Vitamin D3, activated 7-dehydrocholesterol |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
